Skip to content

Category: Reports & Studies

CAREN Argus Rehab (CARE) Study

Source: ClinicalTrials.gov – Retinitis Pigmentosa – CAREN Argus Rehab (CARE) Study Condition:   Retinitis PigmentosaIntervention:   Device: CAREN system trainingSponsor:   The Cleveland ClinicRecruiting Source: ClinicalTrials.gov – Retinitis Pigmentosa – CAREN Argus Rehab (CARE) Study

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Argus II Retinal Prosthesis System – Better Vision RP Study

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Argus II Retinal Prosthesis System – Better Vision RP Study Condition:   Retinitis PigmentosaIntervention:   Device: Argus II Retinal ProsthesisSponsor:   Second Sight Medical ProductsRecruiting Source: ClinicalTrials.gov – Retinitis Pigmentosa – Argus II Retinal Prosthesis System – Better Vision RP Study

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Study of a Suprachoroidal Retinal Prosthesis

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Study of a Suprachoroidal Retinal Prosthesis Conditions:   Retinitis Pigmentosa;   ChoroideremiaIntervention:   Device: 44Ch Bionic Eye DeviceSponsors:   Mobius Medical Pty Ltd.;   Bionic Vision Technologies;   Centre for Eye Research Australia;   Bionics Institute;   University of Melbourne;   Data 61 CSIRO;   Australian National UniversityEnrolling by invitation Source: ClinicalTrials.gov – Retinitis Pigmentosa – Study of a Suprachoroidal Retinal Prosthesis

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Exercise and RP (AVAMC and Emory)

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Exercise and RP (AVAMC and Emory) Condition:   Retinitis PigmentosaIntervention:   Other: Spin exerciseSponsor:   Emory UniversityNot yet recruiting Source: ClinicalTrials.gov – Retinitis Pigmentosa – Exercise and RP (AVAMC and Emory)

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa

Source: ClinicalTrials.gov – Retinitis Pigmentosa – A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa Condition:   Retinitis PigmentosaIntervention:   Biological: CPK850Sponsor:   Novartis PharmaceuticalsNot yet recruiting Source: ClinicalTrials.gov – Retinitis Pigmentosa – A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest